David W. Boyer - 04 Feb 2022 Form 3 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role: Chief Corp. Affairs Officer
Signature: /s/ David Boyer
Issuer symbol: NBIX
Transactions as of: 04 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 09 Feb 2022, 19:01:24 UTC
Next filing: 09 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NBIX	Common Stock						2,075	04 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NBIX	Incentive Stock Option							04 Feb 2022	Common Stock	4,480	$89.23	Direct	F1
holding	NBIX	Non-Qualified Stock Option							04 Feb 2022	Common Stock	43,724	$89.23	Direct	F1
holding	NBIX	Incentive Stock Option							04 Feb 2022	Common Stock	479	$102.90	Direct	F2
holding	NBIX	Non-Qualified Stock Option							04 Feb 2022	Common Stock	11,024	$102.90	Direct	F2
holding	NBIX	Incentive Stock Option							04 Feb 2022	Common Stock	1,281	$117.63	Direct	F3
holding	NBIX	Non-Qualified Stock Option							04 Feb 2022	Common Stock	33,754	$117.63	Direct	F3
holding	NBIX	Incentive Stock Option							04 Feb 2022	Common Stock	1,190	$79.02	Direct	F4
holding	NBIX	Non-Qualified Stock Option							04 Feb 2022	Common Stock	55,907	$79.02	Direct	F4
holding	NBIX	Restricted Stock Unit							04 Feb 2022	Common Stock	10,927		Direct	F5, F6
holding	NBIX	Restricted Stock Unit							04 Feb 2022	Common Stock	1,823		Direct	F6, F7
holding	NBIX	Restricted Stock Unit							04 Feb 2022	Common Stock	5,314		Direct	F6, F8
holding	NBIX	Restriced Stock Unit							04 Feb 2022	Common Stock	8,384		Direct	F6, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted October 1, 2019 and vests at 25% upon first anniversary (October 1, 2020) and remaining 75% vesting in 36 equal monthly installments beginning November 1, 2020.
F2	Option granted February 6, 2020 and vests monthly over four years.
F3	Option granted February 8, 2021 and vests monthly over four years.
F4	Option granted January 31, 2022 and vests monthly over four years.
F5	1/4 of the Restricted Stock Units vested on October 1, 2020 and October 1, 2021. The remaining units vest equally on each of October 1, 2022, October 1, 2023.
F6	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F7	1/4th of the Restricted Stock Units vested on February 6, 2021. The remaining units vest equally on each of February 6, 2022, February 6, 2023, February 6, 2024.
F8	The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 8, 2022, February 8, 2023, February 8, 2024, and February 8, 2025.
F9	The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, January 26, 2026.